Brief: Ryvu Therapeutics Signs Two Deals With Clinscience
July 14 (Reuters) - Neuca SA NEUP.WA :
* SIGNS TWO DEALS WITH CLINSCIENCE, NEUCA UNIT
* DEAL FOR SERVICES RELATED TO MANAGING OF DATA AND
BIOSTATISTICS
FOR CLINICAL TRIAL RIVER-52 AND RIVER-81
* TOTAL FIRST DEAL VALUE AT ABOUT EUR 1.33 MILLION
* TOTAL SECOND DEAL VALUE AT ABOUT EUR 1.26 MILLION
* IF CO SIGNS DEAL WITH AGENCJA BADAN MEDYCZNYCH (ABM),
COSTS
REALTED TO SECOND DEAL WILL BE CO-FINANCED BY ABM
* TO BEGIN SECOND PHASE OF RVU120 CLINICAL TRIALS IN H2
Source text for Eikon: ID:nEM2xNcKka
Further company coverage: NEUP.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys